The Innovation Medicine > 2023 Vol. 1 > No. 1 > 100010
Next Article Previous Article
LETTER   Open Access     Cite

Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?

  • 1.

    Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China

  • 2.

    National Clinical Research Center for Obstetrics and Gynecology, Beijing 100191, China

  • 3.

    Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing 100191, China

  • 4.

    Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China

  • 5.

    Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China

  • 6.

    Therapeutic Drug Monitoring and Clinical Toxicology Center for Peking University, Beijing 100191, China

  • 7.

    Big Data Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China

  • 8.

    These authors contributed equally

    • Show all affliationsShow less
More Information
The Innovation Medicine  1(1),  https://doi.org/10.59717/j.xinn-med.2023.100010  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] March, W.A., Moore, V.M., Willson, K.J., et al. (2010). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25: 544−551. DOI: 10.1093/humrep/dep399.

    View in Article CrossRef Google Scholar

    [2] Teede, H.J., Misso, M.L., Costello, M.F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin. Endocrinol. 89: 251−268. DOI: 10.1111/cen.13795.

    View in Article CrossRef Google Scholar

    [3] Tata, B., Mimouni, N.E.H., Barbotin, A.L., et al. (2018). Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat. Med. 24: 834−846. DOI: 10.1038/s41591-018-0035-5.

    View in Article CrossRef Google Scholar

    [4] Cimino, I., Casoni, F., Liu, X.H., et al. (2016). Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat. Commun. 7: 10055. DOI: 10.1038/ncomms10055.

    View in Article CrossRef Google Scholar

    [5] Xu, H., Feng, G., Shi, L., et al. (2023). PCOSt: A non-invasive and cost-effective screening tool for polycystic ovary syndrome. The Innovation 4: 100407. DOI: 10.1016/j.xinn.2023.100407.

    View in Article CrossRef Google Scholar

    [6] Zhang, X., Xu, H., Feng, G., et al. (2022). Sensitive HPLC-DMS/MS/MS method coupled with dispersive magnetic solid phase extraction followed by in situ derivatization for the simultaneous determination of multiplexing androgens and 17-hydroxyprogesterone in human serum and its application to patients with polycystic ovarian syndrome. Clin. Chim. Acta. 538: 221−230. DOI: 10.1016/j.cca.2022.11.025.

    View in Article CrossRef Google Scholar

    [7] Han, Y., Xu, H., Feng, G., et al. (2022). An online tool using basal or activated ovarian reserve markers to predict the number of oocytes retrieved following controlled ovarian stimulation: A prospective observational cohort study. Front. Endocrinol. 13: 881983. DOI: 10.3389/fendo.2022.881983.

    View in Article CrossRef Google Scholar

    [8] Xu, H., Feng, G., Alpadi, K., et al. (2022). A model for predicting polycystic ovary syndrome using serum AMH, menstrual cycle length, body mass index and serum androstenedione in Chinese reproductive aged population: A retrospective cohort study. Front. Endocrinol. 13: 821368. DOI: 10.3389/fendo.2022.821368.

    View in Article CrossRef Google Scholar

    • CITED BY

  • Cite this article:

    Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome? The Innovation Medicine 1(1), 100010. https://doi.org/10.59717/j.xinn-med.2023.100010
    Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome? The Innovation Medicine 1(1), 100010. https://doi.org/10.59717/j.xinn-med.2023.100010

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(3121) PDF downloads(839) Cited by(0)

Relative Articles

Article Contents
ABOUT THIS ARTICLE

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    Journal links

    {{newsColumn.name}}

    Stay connected

    Copyright © Innovation Press